Blood Pressure Management in Brain Metastases

Introduction to Management Principles

The American Academy of Neurology and other neuro-oncology guidelines recommend maintaining normotension in patients with brain metastases, as there is no evidence to support permissive hypertension in this population 1, 2, 4

Dexamethasone is the cornerstone therapy for symptomatic brain metastases with mass effect and elevated intracranial pressure, with a recommended dose of 4-8 mg/day for mild symptoms and 16 mg/day or higher for moderate to severe symptoms or impending herniation 1, 2, 4
Asymptomatic patients without mass effect do not require prophylactic steroids, according to the National Comprehensive Cancer Network 2, 4

The European Society of Medical Oncology and other guidelines recommend targeting normal blood pressure parameters, typically systolic 120-140 mmHg, unless other comorbidities dictate otherwise 5
Avoiding hypertensive episodes is crucial, as they can worsen vasogenic edema or precipitate hemorrhage, as suggested by the American Heart Association 5
Treating elevated intracranial pressure with dexamethasone, rather than blood pressure manipulation, is the recommended approach, according to the American Academy of Neurology and the National Comprehensive Cancer Network 1, 2, 4, 5

Dexamethasone commonly causes hypertension as an adverse effect, requiring treatment, and patients should be monitored for hyperglycemia, infection risk, and other steroid complications, as recommended by the Journal of the National Comprehensive Cancer Network 6, 5
Corticosteroids should be tapered as rapidly as tolerated to minimize adverse effects, according to the European Society of Medical Oncology and the American Academy of Neurology 1, 4